Guest guest Posted January 20, 1999 Report Share Posted January 20, 1999 Date: 1/21/99 12:10:27 AM Eastern Standard Time BSE TESTING, HUMANS - UK A ProMED-mail post http://www.healthnet.org/programs/promed.html> [see also: CJD (new var.), projections - UK 981214134320 CJD (new var.) - UK: 1990-1998 981207143647 BSE/CJD (new var.) & blood - UK (08) 981127001246] Date: Wed, 20 Jan 1999 10:32:22 -0600 Source: Various News agencies (edited) [For clarity, BSE = Bovine Spongiform Encephalopathy, CJD = Cruetzfeldt- Disease, nvCJD = new variant Cruetzfeldt- Disease, PrPsc = infectious prion. - Mod.TG] The Lancet has the full text of *Investigation of Variant Creutzfeldt- Disease and Other Human Prion Diseases with Tonsil Biopsy Samples* available to registered non-subscribers. It is too long and complex to relay directly. It can be found at http://www.thelancet.com/newlancet/reg/issues/vol353no9148/article183.html>. The article may be summarized essentially as: Infectivity was present throughout the body tissues in nvCJD patients. Infectivity was absent in the body tissues in all other forms of CJD and neurological disorders in patients. Infectivity throughout the body has serious consequences for iatrogenic cases. This suggests: new variant CJD is uniquely different from all other forms of CJD, strengthening the supposition is has a different cause (viz., BSE). The presence of infectivity in non-nervous tissue for nvCJD suggests a similar effect for BSE and amplifies the likelihood of foodborne passage. The presence in non-nervous tissue can be used as a differential diagnosis of nvCJD vs. other CJD. Animals studies have shown that spongiform encephalopathy diseases, which include different forms of CJD, BSE in cattle and scrapie in sheep, tend to reside in the lymph system before attacking the brain. Tonsils are part of the lymph system. These findings suggest that human tonsil biopsy samples may allow presymptomatic diagnosis of nvCJD. Assuming sufficiently sensitive tests were available, then PrPSc will be detectable in human tonsil within months of exposure to BSE. Professor Collinge, of St 's Hospital, London, published in The Lancet the results of a test on 20 patients suspected to have human BSE, known as new variant Creutzfeldt- disease. The test failed to detect the prion protein in 11 patients, whom do not have the disease. The protein was in the tonsils of the remaining 9. Of these, 3 have died and been confirmed by autopsy; 1 has died but no autopsy was performed and 5 are still alive. The Medical Research Council and the Wellcome Trust funded the research that shows the tonsil test could detect the infectious prion protein in nvCJD cases, but not the " classical " CJD. Professor Collinge said this shows how the rogue prion protein behaves quite differently to CJD. Possibly the oral route of exposure, presumed to be the route of BSE infection of patients with nvCJD, results in a more pronounced lymphoreticular phase. Therefore, lymphoreticular tissues from patients with kuru would be interesting to study. Prof Collinge, said that scientists plan to screen thousands of people using the new tonsil test. A significant positive result would provide early warning of a major epidemic to come and allow time for action aimed at averting the disaster. An anonymous mass screening program, planned for later this year, will rely on anonymous tissue donors, tissue removed during routine tonsillectomies and appendectomies. There are now 35 confirmed cases of nvCJD, which may have developed as a result of people consuming BSE contaminated beef, but there are fears that this might be the first signs of an epidemic . Attempts to estimate the future course of the disease have been hampered by a lack of knowledge and a suitable test for early diagnosis. Prof Collinge admitted his concern about the possibility of nvCJD being transmitted via infected surgical instruments. This had always been a theoretical risk, but the conclusive evidence of tonsil infection meant it was now a real possibility. Cost prevents discarding expensive surgical instruments, said Professor Collinge. He added: " There is no means of sterilising surgical instruments adequately for prions. My own view of this is that we may need to consider using more disposable instruments for certain procedures. " Professor Liam son, the Chief Medical Officer said, " Current policy based on advice from the Advisory Committee on Dangerous Pathogens published in April 1998 is when any patient with symptoms of nvCJD, or suspected of having nvCJD, undergoes surgical operation, the instruments must be removed so that they cannot be used again. " Experts from the Joint Advisory Committee on Dangerous Pathogens and the Spongiform Encephalopathy Advisory Committee are considering the surgical implications. They will be advising the Government on setting up new guidelines on the use of disposable surgical instruments to limit the risks to patients. Acting on expert advice the Government has already introduced leucodepletion - removal of white blood cells - for donated blood and banned the use of British-produced plasma in blood products. There is no cure for nvCJD at this time, but research has shown that a drug used in America to treat cystitis may block its spread. Following this new development with BSE in humans, Nick Brown, Minister of Agriculture, announced his decision to make the beef industry pay £21.5 million a year in meat hygiene charges for BSE controls. The result was a clash with leaders of the farming groups. They said the move made a mockery of the Government's £120 million aid to farmers two months ago. The Ministry of Agriculture said it did not know how much the charges would be in individual cases but they would be based " on the current national hourly rate for employment of meat technicians, meat inspectors and official veterinary surgeons " . Charges, to be imposed from March 29, will cover the cost of the Meat and Hygiene Service's enforcement of controls in abattoirs and meat plants to ensure that " high risk " cattle and sheep offals are kept out of the human food chain. [if an animal does not show clinical signs, is not from an infected herd, what makes them *high risk*? - Mod. TG] Until now, costs of checks on specified risk materials, including brain, spinal cord, tonsils and spleen, have been met by the taxpayer. Ben Gill, president of the National Farmers' Union of England and Wales, said: " Specified risk material removal is a public health issue and the industry should not be expected to bear the costs associated with it. " The Government has allowed the industry until Feb 12 to comment on the charges - but the consultation process only covers the details. The decision to pass on the charges has already been taken. [Then what's the point in comments? - Mod. TG] -- ProMED-mail e-mail: promed@... [Although this is a tremendous advancement in testing and hopefully someday treatment of nvCJD, it is unfortunate the government considers it necessary to make the farmers responsible. Yoking the farmer with the responsibility of this and imposing higher cost on an already suffering industry could have grave consequences on the food supply. - Mod.TG] ................................tg/es -- Send all items for posting to: promed@... (NOT to an individual moderator). If you do not give your full name and affiliation, it may not be posted. Send commands to subscribe/unsubscribe, get archives, help, etc. to: majordomo@.... For assistance from a human being, send mail to: owner-promed@... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.